GE HEALTHCARE TECHNOLOGIES INC. (GEHC) Dividend Safety
- Dividend payout ratio · 12 months: Value 3.35%; Formula and calculation Cash dividends paid / net income. Period ending 2026-03-31..
Dividend safety
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | 3.35% | Cash dividends paid / net income. Period ending 2026-03-31. $64.00M ÷ $1.91B × 100 ≈ 3.35% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | 64.00M USD | Payments of Dividends |
| Net income · 12 months | 1.91B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-03-31 | $64.00M | $1.91B | 3.35% |
| 2025-12-31 | $64.00M | $2.08B | 3.07% |
| 2025-09-30 | $62.00M | $2.22B | 2.80% |
| 2025-06-30 | $59.00M | $2.24B | 2.63% |
| 2025-03-31 | $57.00M | $2.18B | 2.61% |
| 2024-12-31 | $55.00M | $1.99B | 2.76% |
| 2024-09-30 | $54.00M | $1.68B | 3.22% |
| 2024-06-30 | $55.00M | $1.58B | 3.48% |
| 2024-03-31 | $55.00M | $1.57B | 3.50% |
| 2023-12-31 | $41.00M | $1.57B | 2.61% |
| 2023-09-30 | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $1.92B | 0.00% |
| 2022-09-30 | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $2.25B | 0.00% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.